Advanced Proteome Therapeutics Receives Notice of Allowance for Patent Claims

3 years ago

Vancouver, British Columbia--(Newsfile Corp. - April 13, 2022) - Advanced Proteome Therapeutics Corporation (TSXV: APC) (FSE: 0E8) ("APC" or the…

ModMed® Ranks #1 for Integrated Practice Management, Revenue Cycle Management and EHR in Surgical Specialties by Black Book Research for 4th Consecutive Year

3 years ago

The health IT company took the top spot in seven key performance indicators in the independent user survey from over…

Alyve Medical, Inc. Appoints New CEO

3 years ago

DENVER--(BUSINESS WIRE)--Alyve Medical, Inc. (formerly NCS America, Inc.), a global medical technology company and leader in data-driven joint kinematics tools,…

Know Your Lemons Breast Self-Exam + Period Tracker App to Help Improve Early Detection for Breast Cancer Nominated for Second Webby Award

3 years ago

Vote Online to Help the Breast Cancer Charity Know Your Lemons Win Internet's Top Honor: vote.webbyawards.comSALT LAKE CITY, UT /…

Neuropathix, Inc. Highlights Positive Preclinical Study Results on Lead Drug Candidate KLS-13019

3 years ago

Published Preclinical Data Shows KLS-13019 More Effective Than Cannabidiol (CBD) in Prevention, Reversal of Chemotherapy-Induced Peripheral Neuropathy (CIPN)DOYLESTOWN, PA /…

NLS Pharmaceutics Ltd. Announces US$4.4 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

3 years ago

ZURICH, SWITZERLAND / ACCESSWIRE / April 13, 2022 / NLS Pharmaceutics Ltd. (NASDAQ:NLSP)(NASDAQ:NLSPW) ("NLS" or the "Company"), a Swiss clinical-stage…

Leafbuyer Technologies, Inc. Announces All Time Record Sales Month

3 years ago

Technology Company Records 58% Year Over Year Sales Growth with the Best Sales Month in Company HistoryDENVER, CO / ACCESSWIRE…

Moderna to Report First Quarter Financial Results on Wednesday, May 4, 2022

3 years ago

CAMBRIDGE, MA / ACCESSWIRE / April 13, 2022 / Moderna, Inc. (NASDAQ:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics…

9 Meters Biopharma Announces Allowance of Patent for Anti-GIP Monoclonal Antibody NM-136 for the Treatment of Serious Metabolic Conditions

3 years ago

RALEIGH, NC / ACCESSWIRE / April 13, 2022 / 9 Meters Biopharma, Inc. (NASDAQ:NMTR), a clinical-stage company pioneering novel treatments…

Sonnet BioTherapeutics Announces First Patient Dosed in Phase 1 Clinical Trial of SON-1010 for Advanced Solid Tumors

3 years ago

PRINCETON, NJ / ACCESSWIRE / April 13, 2022 / Sonnet BioTherapeutics Holdings, Inc., (NASDAQ:SONN) a clinical-stage company developing targeted immunotherapeutic…